John L. Lamattina, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 4,812 shares at $123.65 ($595K) on 2024-11-27, disclosed to the SEC on 2024-12-02.
Open-market sale of $595k LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.65 | 2,406 | $298K | 50.0% |
| 2 | $123.65 | 2,406 | $298K | 50.0% |
| Total | $123.65 avg | 4,812 | $595K | 100% |
| Filing → |
| LGND | SELL | 2025-11-12 | $1.7M | — | Filing → |
| LGND | SELL | 2021-11-17 | $1.6M | — | Filing → |
| IMNM | BUY | 2021-05-26 | $196K | — | Filing → |